Vir Biotechnology (VIR) has released an update.
Vir Biotechnology, Inc. is experiencing a leadership change as their Executive Vice President and Chief Medical Officer, Phil Pang, M.D., Ph.D., plans to depart at the end of March 2024 for family time. The company is actively seeking a new executive to fill the upcoming vacancy.
For further insights into VIR stock, check out TipRanks’ Stock Analysis page.
